Hoffmann-la Roche
Clinical trials sponsored by Hoffmann-la Roche, explained in plain language.
-
Lung cancer immunotherapy combo trial halted early
Disease control TerminatedThis study looked at whether giving two immunotherapy drugs (tiragolumab and atezolizumab) before and after surgery, with or without chemotherapy, is safe and effective for people with a certain type of lung cancer (stage II-IIIB non-small cell lung cancer) that can be removed su…
Phase: PHASE2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Apr 29, 2026 02:24 UTC
-
Dup15q drug trial halted early: what we know
Disease control TerminatedThis study tested a drug called basmisanil in children aged 2 to 14 with Dup15q syndrome, a rare genetic condition that affects development. The goal was to see if the drug could improve daily living skills like communication and movement. The trial was stopped early, and only 7 …
Phase: PHASE2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Apr 28, 2026 13:02 UTC